DEH CELL MEDICINE TECHNOLOGY CO., LTD.
Update：2026/09/15
Industries
Main Industry
Health Care
Main Product/Service
1. Intra-articular injectable medical devices;
2. Wound hemostasis and healing promotion medical devices;
3. Anti-tissue adhesion medical devices;
4. Biomaterials contract research and product development services;
5. Drug delivery systems contract research and product development services;
6. Functional skincare contract research and product development services;
7. Functional food contract research and product development services;
8. Pet health supplement contract research and product development services.
(The content above was translated by AI.)
2. Wound hemostasis and healing promotion medical devices;
3. Anti-tissue adhesion medical devices;
4. Biomaterials contract research and product development services;
5. Drug delivery systems contract research and product development services;
6. Functional skincare contract research and product development services;
7. Functional food contract research and product development services;
8. Pet health supplement contract research and product development services.
(The content above was translated by AI.)
Founded Year
2020
Unified Business No.
83500683
Status
Active
Number of Employees
0
Total Paid-in
Capital
68,500,024 (NT$)
Location of Company
Taiwan
, New Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
DEH CELL MEDICINE TECHNOLOGY CO., LTD. was established in 2020 and is a subsidiary of Lean Bio-Medical Group. The Company is dedicated to the research and development of regenerative medical technologies, as well as the development and sales of advanced medical device products, possessing independent R&D capabilities and a QMS-certified high-end medical device factory. Currently, its wound repair products, hemostatic products, and joint injection products are successfully used in major medical centers and healthcare institutions, having established a strong reputation and brand image. The Company aims to become a leading global regenerative medicine brand and contribute to the enhancement of human health and quality of life.
(The content above was translated by AI.)
(The content above was translated by AI.)
